Abstract
No public abstract is available from the verified source records.
Carter H Scott, Kristin C Prewitt, Nicole E Marshall
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Hyperemesis gravidarum is associated with increased rates of termination of pregnancy and suicidal ideation: results from a survey completed by >5000 participants
10.1016/j.ajog.2021.03.006 · 2021
Neuropsychiatric and mental health outcomes in hyperemesis gravidarum: a retrospective cohort study, Lancet Obstet
2025
The importance of nutrition in pregnancy and lactation: lifelong consequences
10.1016/j.ajog.2021.12.035 · 2022
Unresolved referenced work
2015
Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy
10.1067/mob.2002.123054 · 2002
What obstetrician-gynecologists should know about substance use disorders in the perinatal period
10.1097/aog.0000000000004657 · 2022
Self-reported medical and nonmedical cannabis use among pregnant women. Medical and nonmedical cannabis use among pregnant women in the United States
10.1001/jama.2019.7982 · 2019
Understanding how persons with maternal opioid use disorder experience public food assistance programs WIC and SNAP, Subst
2025
The Nutritional Online sUrvey for pRegnancy Induced Sickness & Hyperemesis (NOURISH) study: results from the first trimester
10.1111/jhn.13224 · 2023
The impact and management of hyperemesis gravidarum: current and future perspectives
10.1002/ijgo.70165 · 2025
ACOG Practice Bulletin No. 189: nausea and vomiting of pregnancy
10.1097/aog.0000000000002456 · 2018
Hyperemesis gravidarum and nutritional support
10.14309/ajg.0000000000001957 · 2022
Safety of home parenteral nutrition during pregnancy
10.1016/j.clnu.2015.12.001 · 2017
Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department
10.1186/s12245-022-00446-0 · 2022
Diagnostic criteria for cannabis withdrawal syndrome
10.1016/j.drugalcdep.2011.11.007 · 2012
Prenatal cannabis use and maternal pregnancy outcomes
10.1001/jamainternmed.2024.3270 · 2024
Prenatal cannabis use and neonatal outcomes
10.1001/jamapediatrics.2025.0689 · 2025
Prenatal delta-9-tetrahydrocannabinol exposure alters fetal neurodevelopment in rhesus macaques
10.1038/s41598-024-56386-7 · 2024
Gastroduodenal disorders
10.1053/j.gastro.2016.02.011 · 2016
Cannabinoid hyperemesis syndrome: a 6-year audit of adult presentations to an urban district hospital
10.1111/1742-6723.13944 · 2022
Prevalence of cannabis use has significantly increased in patients with cyclic vomiting syndrome
10.1111/nmo.13806 · 2020
Cannabinoid hyperemesis syndrome: pathophysiology and treatment in the emergency department
10.1016/j.jemermed.2017.12.010 · 2018
Cannabis use patterns and blood profiles in adolescent cannabinoid hyperemesis syndrome
10.1097/pec.0000000000003495 · 2026
Resolution of cannabinoid hyperemesis syndrome with benzodiazepines: a case series, Isr
2019
Treatment of cannabis hyperemesis syndrome using haloperidol in a pregnant patient: case report
10.1097/jcp.0000000000001579 · 2022
The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome
10.1080/15563650.2018.1564324 · 2019
Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review
10.1002/phar.1931 · 2017
No additional external references are available.